Skip to main content
OpenTrials

Clinical trial condition

Depressive Disorder

Explore clinical trials studying Depressive Disorder. Study availability and eligibility vary by location and protocol.

2,799 public trials 431 recruiting studies
Refine in advanced search Browse all conditions

Depressive Disorder trial results

Completed

A Comparison of Sertraline-reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression.

NCT00636246

Conditions
Depressive Disorder, Depressive Disorder, Major, Mental Disorders, +1 more
Locations
  • Pfizer Investigational Site Viljandi, Viljandi Mk., Estonia
  • Pfizer Investigational Site Pärnu, Estonia
  • Pfizer Investigational Site Tallinn, Estonia
  • Pfizer Investigational Site Tartu, Estonia
View all 17 locations
View Trial Details
Completed

A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression

NCT00644982

Conditions
Depressive Disorder, Depressive Disorder, Major, Mental Disorders, +1 more
Locations
  • Pfizer Investigational Site Cairns, Queensland, Australia
  • Pfizer Investigational Site Everton Park, Queensland, Australia
  • Pfizer Investigational Site North Cairns, Queensland, Australia
  • Pfizer Investigational Site Box Hill, Victoria, Australia
View all 14 locations
View Trial Details
Completed

Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia

NCT04437342

Conditions
Behavior, Behavioral Symptoms, COVID-19, +23 more
Locations
  • "Elena Venizelou" General and Maternity Hospital of Athens Athens, Attica, Greece
  • Aretaieio University Hospital Athens, Attica, Greece
  • Alexandra Genaral Hospital Athens Athens, Greece
  • University of Ioannina Health Science Ioannina, Greece
View Trial Details
Completed

Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)

NCT02371980

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations
  • NoesisPharma Phoenix, Arizona, United States
  • SW Biomedical Research, LLC Tucson, Arizona, United States
  • CNS Research Science, Inc. Cerritos, California, United States
  • Collaborative Neuroscience Network, LLC Garden Grove, California, United States
View all 79 locations
View Trial Details
Completed

Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)

NCT01110902

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • University of Alabama at Birmingham, Department of Psychiatry Birmingham, Alabama, United States
  • ATP Clinical Research Costa Mesa, California, United States
  • Valley Clinical Research El Centro, California, United States
  • Collaborative Neuroscience Network Garden Grove, California, United States
View all 45 locations
View Trial Details
Completed

A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)

NCT00463242

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site National City, California, United States
  • Novartis Investigative Site Orange, California, United States
  • Novartis Investigative Site Pasadena, California, United States
View all 47 locations
View Trial Details

Related conditions